Myocarditis Following COVID-19 Vaccination: Cardiac Imaging Findings in 118 Studies.
Tomography
; 8(4): 1959-1973, 2022 07 30.
Article
in English
| MEDLINE | ID: covidwho-1969479
ABSTRACT
We reviewed the reported imaging findings of myocarditis in the literature following COVID-19 vaccination on cardiac imaging by a literature search in online databases, including Scopus, Medline (PubMed), Web of Science, Embase (Elsevier), and Google Scholar. In total, 532 cases of myocarditis after COVID-19 vaccination were reported (462, 86.8% men and 70, 13.2% women, age range 12 to 80) with the following distribution Pfizer-BioNTech 367 (69%), Moderna 137 (25.8%), AstraZeneca 12 (2.3%), Janssen/Johnson & Johnson 6 (1.1%), COVAXIN 1 (0.1%), and unknown mRNA vaccine 9 (1.7%). The distribution of patients receiving vaccine dosage was investigated. On cardiac MR Imaging, late intravenous gadolinium enhancement (LGE) was observed mainly in the epicardial/subepicardial segments (90.8%, 318 of 350 enhancing segments), with the dominance of inferolateral segment and inferior walls. Pericardial effusion was reported in 13.1% of cases. The vast majority of patients (94%, 500 of 532) were discharged from the hospital except for 4 (0.7%) cases. Post-COVID-19 myocarditis was most commonly reported in symptomatic men after the second or third dose, with CMRI findings including LGE in 90.8% of inferior and inferolateral epicardial/subepicardial segments. Most cases were self-limited.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
/
Myocarditis
Type of study:
Observational study
/
Reviews
Topics:
Long Covid
/
Vaccines
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
/
Young adult
Language:
English
Journal:
Tomography
Year:
2022
Document Type:
Article
Affiliation country:
Tomography8040164
Similar
MEDLINE
...
LILACS
LIS